BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27468582)

  • 1. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
    Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
    Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.
    Hashad DI; Hashad MM; Talaat IM; Ibrahim MA
    Genet Test Mol Biomarkers; 2011 Oct; 15(10):667-70. PubMed ID: 21631298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
    Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
    Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
    Goessl C; Krause H; Müller M; Heicappell R; Schrader M; Sachsinger J; Miller K
    Cancer Res; 2000 Nov; 60(21):5941-5. PubMed ID: 11085508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered methylation of multiple genes in carcinogenesis of the prostate.
    Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
    Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
    Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
    J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
    Wu T; Giovannucci E; Welge J; Mallick P; Tang WY; Ho SM
    Br J Cancer; 2011 Jun; 105(1):65-73. PubMed ID: 21654682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
    Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
    Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
    Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
    Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
    BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV; Guo Z; Epstein JI; Sidransky D
    J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
    Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
    Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
    Kollermann J; Kempkensteffen C; Helpap B; Schrader M; Krause H; Muller M; Miller K; Schostak M
    BMC Urol; 2006 Jun; 6():15. PubMed ID: 16803634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
    Crocitto LE; Korns D; Kretzner L; Shevchuk T; Blair SL; Wilson TG; Ramin SA; Kawachi MH; Smith SS
    Urology; 2004 Oct; 64(4):821-5. PubMed ID: 15491741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.